Google Search Trends to Assess Public Interest and Concern About Pegcetacoplan for the Treatment of Geographic Atrophy

被引：0

作者：

Mansour, Hana A. ^{[1
]}

Xu, David ^{[1
]}

Cohen, Michael N. ^{[1
]}

Deaner, Jordan D. ^{[1
]}

Hsu, Jason ^{[1
]}

Yonekawa, Yoshihiro ^{[1
]}

Orlin, Anton ^{[1
]}

Sivalingam, Meera D. ^{[1
]}

Sridhar, Jayanth ^{[2
]}

Kuriyan, Ajay E. ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Wills Eye Hosp, Mid Atlantic Retina, Philadelphia, PA USA

[2] Ol View Univ Calif Angeles Med Ctr, Angeles Cty Dept Hlth Serv, Los Angeles, CA USA

来源：

OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2024年 / 55卷 / 08期

关键词：

MACULAR DEGENERATION; UNITED-STATES; SECONDARY;

D O I：

10.3928/23258160-20240409-04

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

OBJECTIVE: To assess global trends in interest surrounding the newly Food and Drug Administration (FDA)-approved treatment for geographic atrophy, (GA), Syfovre (pegcetacoplan), and related searches. METHODS: We utilized Google Trends, in order to gauge the public interest in Syfovre from October 16, 2022, to October 8, 2023. RESULTS: Notable spikes in relative search volumes (RSV)s for "Syfovre" were observed in mid-to-late February 2023, and in March and April 2023, coinciding with the drug's FDA approval and introduction to the market. Of the various side effects, retinal vasculitis garnered the most significant attention, with a sharp rise in RSV in mid-July 2023. Geographic variation was evident, with the highest RSVs for "Syfovre" originating from users on the East Coast. CONCLUSION: Google Trends proves to be a useful tool for gaining insight into public interest in pegcetacoplan as a treatment for GA.

引用

页码：452 / 460

页数：9

共 26 条

[1]

[Anonymous], 2022, Nation continues to age as it becomes more diverse

[2]

[Anonymous], 2023, Apellis announces preliminary U.S. net revenues of approximately $74 million for SYFOVRE (pegcetacoplan injection) in the third quarter of 2023

[3]

[Anonymous], 2023, Apellis Partners with Acclaimed Actor Henry Winkler to Raise Awareness of Geographic Atrophy (GA) for the GA Won't WaitTM Campaign

[4]

[Anonymous], 2024, Ask your retina specialist about the benefits of treatment with VABYSMO

[5]

Apellis Pharmaceuticals, 2024, SyfovreTM (Pegcetacoplan Injection)

[6] Predicting COVID-19 Incidence Through Analysis of Google Trends Data in Iran: Data Mining and Deep Learning Pilot Study [J].

Ayyoubzadeh, Seyed Mohammad ;

Ayyoubzadeh, Seyed Mehdi ;

Zahedi, Hoda ;

Ahmadi, Mahnaz ;

Kalhori, Sharareh R. Niakan .

JMIR PUBLIC HEALTH AND SURVEILLANCE, 2020, 6 (02) :192-198

[7] Heatmapper: web-enabled heat mapping for all [J].

Babicki, Sasha ;

Arndt, David ;

Marcu, Ana ;

Liang, Yongjie ;

Grant, Jason R. ;

Maciejewski, Adam ;

Wishart, David S. .

NUCLEIC ACIDS RESEARCH, 2016, 44 (W1) :W147-W153

[8] THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET [J].

Boyer, David S. ;

Schmidt-Erfurth, Ursula ;

Campagne, Menno van Lookeren ;

Henry, Erin C. ;

Brittain, Christopher .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (05) :819-835

[9]

Centers for Disease Control and Prevention, 2022, Vision and Eye Health Surveillance System (VEHSS)

[10] YouTube Dominance in Sustainability of Gaining Knowledge via Social Media in University Setting-Case Study [J].

Cerna, Miloslava ;

Borkovcova, Anna .

SUSTAINABILITY, 2020, 12 (21) :1-18

← 1 2 3 →